Updated results of a phase 1, first-in-human study of talquetamab, a G protein-coupled receptor family C group 5 member D (GPRC5D) x CD3 bispecific antibody, in relapsed/refractory multiple myeloma (MM)

Authors :: Berdeja, JG
Krishnan, AY
Oriol, A
van de Donk, NWCJ
Rodriguez-Otero, P
Askari, E
Mateos, MV
Minnema, MC
Costa, LJ
Verona, R
Girgis, S
Prior, T
Hilder, B
Russell, JS
Goldberg, JD
Chari, A
Source :: Journal of Clinical Oncology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Publication Year :: 2021
Publisher :: American Society of Clinical Oncology, 2021.

ISSN :: 0732183X
Database :: OpenAIRE
Journal :: Journal of Clinical Oncology, r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol, instname
Accession number :: edsair.RECOLECTA.....d6b27a4509216ce342137d6684758acd

Tools